Advaxis Inc. (NASDAQ:ADXS) Stock Suddenly Soars 28% Will The Rally Continue?
Advaxis Inc. (NASDAQ:ADXS) jumped 28% after announcing its Q3 2021 financial results and corporate update. During the quarter, the company signed a definitive merger agreement with Biosight Ltd with the proposed merger creating a public company that will operate as Biosight Therapeutics. The combined company will have cash, cash equivalents, and marketable securities of around $50 million at closing. Over the next 18 months, the combined company expects to report…